Screening for Cancer: Considerations for Low- and Middle-Income Countries
Abstract
Explains that a cancer screening program should consider the burden of the cancer in the population at risk, cost-effectiveness, and the success in how well the test works. Key terms defined include opportunistic screening, organized screening, population-based screening, high-risk screening, and several types of bias (lead-time bias, length bias, and overdiagnosis). Ethical and cost-effectiveness considerations determine that benefits outweigh possible harms. Three cancers discussed more fully are (1) breast cancer for which several approaches to screening are analyzed; (2) cervical cancer which may have the greatest potential for screening-detected reductions in cancer mortality; and (3) colorectal cancer which becomes more common as less developed countries adopt Western lifestyles. A diagonal approach to screening involves an umbrella of maternal or reproductive health policy to encompass both cervical and breast cancer and creates a platform onto which other preventive and wellness care can be added. Developing a screening policy for cancer examines choice of diagnostic technologies and follow-up interventions, the age groups targeted, referral and enrollment strategies, and quality assurance processes.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Colorectal cancer screening with noninvasive procedures, such as the fecal immunochemical test, may be cost-effective in many transitioning regions given its high specificity, good sensitivity, and ease of use.
“there is increasing evidence that colorectal cancer screening with noninvasive procedures, such as the fecal immunochemical test, given its high specificity, good sensitivity, and ease of use, may be cost-effective in many transitioning regions.[67][68][69]”
From Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. (2024) · cites this paper as [67]
Cites
Using evidence: How research can inform public services
Nutley, S. M., Walter, I., & Davies, H. T. O. (2007) · doi:10.2307/j.ctt9qgwt1 · Cited by 808 · see citing works
E-health in low- and middle-income countries: findings from the Center for Health Market Innovations
Lewis, T., Synowiec, C., Lagomarsino, G., & Schweitzer, J. (2012) · Bulletin of the World Health Organization · doi:10.2471/blt.11.099820 · Cited by 319 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Bray, F., Laversanne, M., Sung, H., Ferlay, J., Siegel, R. L., Soerjomataram, I., & Jemal, A. (2024) · CA: a cancer journal for clinicians · doi:10.3322/caac.21834 · Cited by 27,064 · see citing works
- Authors
- Sullivan, T., Sullivan, R., & Ginsburg, O. M.
- Affiliations
- University of Toronto (CA)
- Venue
- Disease Control Priorities, Third Edition (Volume 3): Cancer
- Publisher
- The World Bank
- Published
- 2015-11
- Pages
- 211-222
- OpenAlex
- W2410823298
- Cited by
- 38
- References
- 2
- Citations by year
- 2026: 2 · 2025: 5 · 2024: 2 · 2023: 8 · 2022: 4 · 2021: 3 · 2020: 6 · 2019: 2 · 2018: 1 · 2017: 3 · 2016: 2
- FWCI
- 3.99
- Type
- book chapter
- Language
- en
- Open access
- closed
- Locations
- World Bank, Washington, DC eBooks (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Women's cancer prevention and management
- Health Sciences › Medicine › Oncology › Colorectal Cancer Screening and Detection
- Keywords
- cancer screening, low- and middle-income countries, cost-effectiveness, lead-time bias, length bias, overdiagnosis, breast cancer screening, cervical cancer screening, colorectal cancer screening, opportunistic screening, organized screening programs, mass screening, high-risk screening, screening policy, cancer mortality reduction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review